Science@UH at 50: Chronicling Discovery, Innovation and Impact
November 17, 2026
UH Research & Education Institute
In September 2022, Science@UH was launched with a simple goal of bringing listeners inside the discoveries shaping the future of medicine at University Hospitals. The inaugural episode featured Daniel Spratt, MD, discussing advances in prostate cancer research. Four years later, the podcast will hit a major milestone with its 50th episode.
Science@UH has explored scientific discovery across a wide spectrum of health challenges, including cancer, neuroscience, cardiovascular disease, women’s health, artificial intelligence, population health and emerging technologies showcasing the depth of research taking place across University Hospitals and its academic partners. While the topics vary, they are all connected by a shared commitment to improving health through innovation, collaboration, and scientific discovery.
"Over the past four years, the podcast has grown from a small audience to listeners in more than 50 countries, with engagement increasing more than threefold and nearly eight out of every ten audience interactions now happening through video,” says Daniel Simon, MD, President, Academic & External Affairs and Chief Scientific Officer, Interim President, Harrington Heart & Vascular Institute, Ernie and Patti Novak, Distinguished Chair in Health Care Leadership, University Hospitals Health System, and Professor of Medicine and Senior Associate Dean for Academic Affairs at Case Western Reserve University School of Medicine. “These milestones reinforce what we see every day at University Hospitals, which is the tremendous impact of scientific discovery by outstanding clinician-scientists and clinical researchers on patients and communities. We are accelerating the development of new drugs, devices and cell-based therapies from the bench-to-bedside, bringing hope to patients and their families."
The discoveries feature on the podcast span a wide range of specialties and disciplines, reflecting the breadth of research being conducted across University Hospitals and its academic partners.
Cancer: from Single Discoveries to Systems of Care
Cancer research has been a cornerstone of the series, highlighting the depth of University Hospitals’ oncology expertise. Featured episodes have examined advances in pancreatic (Episode 2) and lung cancer detection (Episode 10), CAR T-Cell therapy (Episode 44), breast cancer treatment (Episode 34), and innovative technologies such as EsoCheck™ and EsoGuard™ (Episode 17) that aim to identify disease at an early stage and improve patient outcomes. From earlier detection to more personalized and effective treatments, these conversations illustrate how advances in prevention, diagnosis, and treatment are changing the cancer care continuum.
Neuroscience: The Brain from Every Angle
Neuroscience has been another prominent focus. Episode 23, "Redefining Stroke Therapy: A Paradigm Shift Across the Globe," detailed breakthroughs that transformed stroke treatment worldwide, demonstrating how research conducted at UH can impact clinical practice beyond Northeast Ohio.
The neuroscience catalog since then has been strikingly wide-ranging, covering the prion paradigm in neurodegenerative disease (Episode 35), exercise as therapy for Parkinson's disease (Episode 32), EEG biomarkers and the teenage brain (Episode 40), barriers to understanding autism and brain tumors (Episode 42), and the science of smell as a window into brain health (Episode 41). Most recently, Episode 46 explored the potential of 15-PGDH to protect memory following traumatic brain injury and in Alzheimer's disease, emphasizing how new biological insights are opening doors to earlier intervention and novel therapies.
The Heart, Metabolism, and the GLP-1 Era
The cardiovascular and cardiometabolic episodes read, in retrospect, like a preview of where medicine is headed. Episode 33 examined the transition of valve therapy from research to real-world application, while Episode 36 focused on heart failure research extending across institutional and geographic boundaries. In May 2026, Episode 43 "From GLP-1 to Triple Agonists: Transforming Cardiometabolic Care" delved into one of the most consequential shifts in chronic-disease management in a generation. These conversations are complemented by emerging research on the microbiome and mycobiome (Episode 30), pointing to a growing understanding of the connections among metabolism, inflammation, and chronic disease. These episodes capture how cardiovascular and metabolic research are converging to address some of the leading causes of illness and death worldwide.
Women's Health: Closing Long-standing Gaps
Some of the series' most impactful episodes have focused on conditions that affect millions of women yet remain underrecognized or insufficiently studied. Episode 20 traced the evolution of female sexual health research and emerging treatment approaches. Episode 27 discussed how AI and patient-centered research can advance female pelvic floor health. Episode 45 challenged longstanding assumptions about urinary incontinence with a simple but powerful message that "common doesn't mean normal". Episode 47 spotlighted how ovarian tissue transplants at UH are offering new hope to women with ovarian insufficiency. Collectively, these conversations affirm a commitment to addressing longstanding gaps in women’s health research and care while expanding opportunities for more effective treatments and improved quality of life.
Beyond Discovery: The Tools, Partnerships and People Behind Innovation
Beyond individual discoveries, the podcast has also provided insight into the people, technologies, and partnerships that make research possible. Episodes on artificial intelligence (Episode 4), radiology innovation and AI-enabled imaging (Episode 14), and MR fingerprinting (Episode 24) offered a closer look at how data and advanced technologies are transforming the way diseases are detected, characterized and treated. These conversations make clear that progress in modern healthcare depends not only on scientific advances, but also on the infrastructure, tools and collaborative networks that help translate discoveries into better patient care.
Other episodes covered community-engaged research (Episode 8), the effects of policy and environment on health outcomes (Episode 13) and efforts to bridge the gaps in diabetes care during the transition from adolescence to adulthood (Episode 21). These conversations attest to the importance of research that extends beyond the laboratory, bringing researchers together, healthcare professionals, patients and communities to improve health outcomes.
Lessons from Fifty Episodes
Across every area of research featured on Science@UH, collaboration consistently emerges as a driving force behind meaningful scientific advances. The challenges facing healthcare today are too complex to be solved by any single individual or discipline. Drawing on diverse expertise, team science transforms promising ideas into discoveries that improve lives.
The podcast serves not only as a chronicle of scientific progress, but also as a celebration of the people and shared efforts that make innovation possible. For researchers, clinicians, patients and community members alike, the podcast offers an accessible way to engage with the discoveries shaping the future of healthcare.
As Science@UH looks ahead to its next fifty episodes, it will continue to showcase the people, partnerships and discoveries shaping the future of healthcare. The stories may differ, but the mission remains the same: bringing listeners closer to the science that is transforming lives.
Tags: Research, Research & Education